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Abstract: The assumption that RNA can be readily
classified into either protein-coding or non-protein–
coding categories has pervaded biology for close to 50
years. Until recently, discrimination between these two
categories was relatively straightforward: most transcripts
were clearly identifiable as protein-coding messenger
RNAs (mRNAs), and readily distinguished from the small
number of well-characterized non-protein–coding RNAs
(ncRNAs), such as transfer, ribosomal, and spliceosomal
RNAs. Recent genome-wide studies have revealed the
existence of thousands of noncoding transcripts, whose
function and significance are unclear. The discovery of this
hidden transcriptome and the implicit challenge it
presents to our understanding of the expression and
regulation of genetic information has made the need to
distinguish between mRNAs and ncRNAs both more
pressing and more complicated. In this Review, we
consider the diverse strategies employed to discriminate
between protein-coding and noncoding transcripts and
the fundamental difficulties that are inherent in what may
superficially appear to be a simple problem. Misannota-
tions can also run in both directions: some ncRNAs may
actually encode peptides, and some of those currently
thought to do so may not. Moreover, recent studies have
shown that some RNAs can function both as mRNAs and
intrinsically as functional ncRNAs, which may be a
relatively widespread phenomenon. We conclude that it
is difficult to annotate an RNA unequivocally as protein-
coding or noncoding, with overlapping protein-coding
and noncoding transcripts further confounding this
distinction. In addition, the finding that some transcripts
can function both intrinsically at the RNA level and to
encode proteins suggests a false dichotomy between
mRNAs and ncRNAs. Therefore, the functionality of any
transcript at the RNA level should not be discounted.
Introduction
Numerous studies have demonstrated that the true catalog of
RNAs encoded within the genome (the ‘‘transcriptome’’) is more
extensive and complex than previously thought (reviewed in [1–
3]). In humans and mice, for instance, it has become apparent that
the vast majority of the genome is transcribed, often in intricate
networks of overlapping sense and antisense transcripts, many of
which are alternatively spliced [1,4–8]. However, mRNAs account
for only ,2.3% of the human genome [1,9], and therefore the vast
majority of this unexpected transcription, sometimes referred to as
‘‘dark matter’’ [10,11], appears to be non-protein–coding.
Unsurprisingly, a great deal of attention is now focused on the
noncoding transcriptome. Dominating this field of inquiry has
been the discovery of thousands of small RNAs (,200 nt in
length). Many of these have since been classified into novel
categories (e.g., microRNAs, PIWI-associated RNAs, and endog-
enous small interfering RNAs) on the basis of function, length,
biogenesis, structural/sequence features, and protein-binding
partners (reviewed in [12]). Interestingly, however, long ncRNAs
(.200 nt) appear to comprise the largest portion of the
mammalian noncoding transcriptome. Tiling array studies of the
human genome, for instance, revealed that the majority of
transcription occurs as long ncRNAs [13], some of which may
be precursors for smaller RNAs, but many of which are detected as
relatively stable polyadenylated and non-polyadenylated tran-
scripts [8,14].
The biological significance of these long ncRNAs is controver-
sial. Despite an increasing number of long ncRNAs having been
shown to fulfill a diverse range of regulatory roles (reviewed in
[15,16]), the functions of the vast majority remain unknown and
untested. And while this is also true of small RNAs to some extent,
long ncRNAs—unlike their smaller counterparts—lack obvious
features to allow a priori functional categorization or prediction.
Furthermore, the exact prevalence of long ncRNAs remains
subject to significant interpretation and debate. For instance, the
FANTOM and H-Invitational consortiums annotated compre-
hensive full-length cDNA collections in mouse and human,
respectively [5,17]. Despite using similar methods of cDNA
library construction, the two groups came up with very different
prevalence estimates for long ncRNAs within the mammalian
genome: in mouse, 33% of transcripts (34,030/102,281) were
annotated as noncoding; by comparison, only 7% of human
transcripts (1,377/21,037) were identified as ncRNAs. That such
divergent estimates exist highlights how difficult it has become to
discriminate between long ncRNAs and mRNAs. To better
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distinguish noncoding from protein-coding are considered below.
Strategies to Discriminate between ncRNAs and
mRNAs
Open reading frame length. One of the most fundamental
criteria used to distinguish long ncRNAs from mRNAs is ORF
length. Since short putative ORFs can be expected to occur by
chancewithinlongnoncoding sequences,minimumORFcutoffsare
usually applied to reduce the likelihood of falsely categorizing
ncRNAs as mRNAs. For instance, the FANTOM consortium
originally used a cutoff of 300 nt (100 codons) to help identify
putative mRNAs [18]. This somewhat arbitrary threshold is
consistent with the observation that .95% of proteins in public
databases such as Swiss-Prot and the International Protein Index are
.100 aa in length [19], and has subsequently been shown to display
a high level of concordance with more sophisticated discrimination
methods [20]. This length is also approximately two standard
deviations above the average length of ORFs in a one kilobase
random sequence (Figure 1).
Using putative ORF length alone, although straightforward to
apply across large datasets, is problematic for various reasons.
First, bona fide long ncRNAs will by chance contain putative
ORFs that are quite long. For instance, H19, Xist, Mirg, Gtl2, and
KcnqOT1 all have putative ORFs .100 codons, but have been
characterized as functional ncRNAs [15]. Applying a traditional
ORF cutoff of 300 nt will therefore misclassify many ncRNAs as
mRNAs, and this is especially true for very long ncRNAs, as
illustrated in Figure 1. For example, murine Xist is ,15 Kb in
size [21] and contains a putative ORF of 298 aa, which led to the
erroneous conclusion that it was a protein-coding gene when first
discovered [22]. Second, with a cutoff of 300 nt, proteins ,100
aa in size may also be incorrectly classified as ncRNAs. The
potential scale of such errors is significant, given recent estimates
that the mammalian proteome contains ,3,700 proteins below
this size [19]. To minimize such errors, ORF length cutoffs can
be reduced, which is exactly what the H-Invitational consortium
did in applying a threshold of 60 nt (20 codons) in their
annotation pipeline [17]. However, such a low threshold will
falsely underestimate the number of ncRNAs, which probably
explains to a large extent why the numbers of H-Invitational
ncRNAs are so small. Finally, it is notable that even at very low
cutoffs, some atypical proteins will still be missed. The tarsal-less
(tal) gene, for example, controls tissue folding in Drosophila and
encodes a ,1.5 Kb transcript [23], whose putative ORFs are all
extremely short. Tal was therefore initially classified as an ncRNA
[24], but it has subsequently been shown that it is actually
translated into multiple 11 aa peptides that fulfill the function of
the gene [23]. With examples such as this that highlight the perils
of dismissing even the shortest of putative ORFs, one wonders
how many other presumed ncRNAs encode real albeit very short
proteins.
ORF conservation. Given the problems of relying solely
upon ORF size, an alternative approach to discriminating long
ncRNAs from mRNAs is to assess putative ORFs for similarity to
known proteins or protein domains, since such homology provides
indirect evidence of function as an mRNA. Indeed, the vast
majority of putative human ORFs without cross-species
counterparts is likely to be random occurrences [25], and many
studies of individual ncRNAs now cite a lack of ORF conservation
to argue against function as an mRNA. Several tools and resources
are available for such analysis, including BLASTX [26], rsCDS
[27], Pfam [28], and SUPERFAMILY [29].
Figure 1. Incidence of open reading frames (ORFs) in randomly generated transcripts of increasing length. Twenty thousand
transcripts of varying length and random nucleotide composition were computationally generated and scanned for ORFs. The maximum ORF and
transcript lengths were plotted and fitted to a logarithmic curve. The shaded regions represent incidences of randomly occurring ORFs at 1, 2, or 3
standard deviations from the mean. The red line indicates the 300 nt ORF threshold that is commonly used to distinguish protein-coding genes in
transcript classification pipelines. Therefore, this plot illustrates that for transcripts longer than ,1000 bp, such a threshold may define transcripts as
protein-coding that would be expected to occur by chance. The function y=91.Ln(x)2330, which approximates random ORF incidence according to
transcript length at two standard deviations above the mean (i.e., 95% confidence interval, indicated in green), could be used to discriminate
noncoding from protein-coding transcripts in a transcript-length–dependent manner.
doi:10.1371/journal.pcbi.1000176.g001
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used to distinguish ncRNAs from mRNAs on a transcriptome-
wide scale. These comparative approaches include the programs
CSTminer [30,31] and CRITICA [32], both of which exploit the
tendency for protein-coding sequences to favor synonymous base
changes (i.e., changes that do not result in amino acid substitution)
over non-synonymous ones, but are limited by the numbers of
genomes available for comparison and the rapid evolution of many
ncRNAs [33], making it difficult to detect orthologous sequences.
There are also other problems in using ORF conservation to
identify protein-coding RNAs. First, these approaches are limited
by the comprehensiveness and accuracy of current protein
annotations. For instance, Xist was annotated as a protein-coding
gene in public databases (Swiss-Prot accession: P27571) for almost
fifteen years after its characterization as a functional ncRNA [21],
which led to inadvertent misclassification by a computational
pipeline in one recent study [34]. Second, some ncRNAs have
evolved from protein-coding genes [35,36], and so will retain
remnant signatures of and homologies to mRNAs. Finally,
particularly in less complex eukaryotes, such as yeast, absence of
ORF conservation even with closely related species, does not
guarantee an absence of function. Indeed, a recent study of orphan
ORFs in Saccharomyces cerevisiae that had been initially annotated as
spurious showed that many produced detectable transcripts and/
or translated products [37].
Structural approaches. The approaches described above are
primarily designed to identify mRNAs. Consequently, long ncRNAs
are typically defined indirectly through an absence of mRNA-like
characteristics. In contrast, a number of studies have used the
presenceofconservedpredictedRNAsecondarystructuretoidentify
ncRNAs imputed to have functional properties. These include the
programs QRNA [38], RNAz [39], and EvoFOLD [40]. However,
using these programs to classify transcripts as ncRNAs is likely to
lead to significant false positive and false negative discoveries, since
conserved secondary structures are also commonly found in mRNAs
(especially 39 UTRs), and functional ncRNAs may contain
secondary or tertiary structures with non-canonical base
interactions [41] that are not considered by structural prediction
programs.
Experimental strategies. As well as computational
methods, several experimental strategies have also been used to
try to distinguish mRNAs and ncRNAs. For instance, in vitro
translation assays have been performed in individual cases to test
whether a putative ORF is translated into protein [23,42,43].
Positive translation results gives an indication that a transcript is an
mRNA, but one needs to interpret such results with caution, since
spurious ORFs have previously been translated in vitro and
antibodies have even been generated against the resultant protein
[44]. Meanwhile, negative translation results also tend to be
inconclusive. Another experimental method is to assess whether a
transcript is associated with polysomes [21], as would be expected
for mRNAs that are actively translated, but again such a method is
far from definitive.
Artifact filtering. Reliable classification of novel transcripts
into mRNAs or ncRNAs is predicated on the assumption that they
represent genuine, full-length transcripts. However, incomplete
reverse transcription, internal priming of pre-mRNAs, and
genomic contamination can all result in the generation of
spurious or truncated transcripts, many of which are likely to
masquerade as ncRNAs [45]. To help address this issue, various
approaches have been used to filter out potential experimental
artifacts. The FANTOM3 consortium, for instance, whittled down
their original list of 34,030 ncRNAs to a shortlist of 3,652
confidently full-length ncRNAs by requiring that transcripts have
stringent support at their 59 and 39 ends [5]. Another method
excluded ncRNAs that mapped to the same genomic strand and
locus as an mRNA, in the belief that such transcripts were likely to
represent spuriously truncated mRNAs [18]. Notably, both these
approaches are likely to filter out genuine ncRNAs, since not only
are very long (.5 Kb) ncRNAs such as Xist and Air unable to be
successfully captured as full-length transcripts using current
cloning and sequencing approaches [34], but many genomic loci
are also now known to harbor overlapping and/or interleaving
mRNAs and ncRNAs on the same strand [13].
Combination strategies. Many of the strategies described
above are complementary, and can be combined to good effect.
For instance, CRITICA uses statistical techniques in addition to its
comparative approach [32] and was the best-performing of ten
bioinformatic methods used to discriminate ncRNAs and mRNAs
from the FANTOM cDNA collection [20]. A number of other
programs use sophisticated statistical approaches based on
integrating a range of characteristic protein-coding signatures,
including splice acceptor/donor sites, polyadenylation signals,
ORF length, and sequence homology. For example, to
discriminate coding regions, DIANA-EST employs a
combination of artificial neural networks and statistical
approaches [46], and ESTScan uses a hidden Markov model
approach [47].
Two recently described tools, CPC and CONC, use supervised
learning algorithms known as support vector machines to
distinguish mRNAs from ncRNAs [48,49]. These algorithms take
into consideration multiple features such as peptide length, amino
acid composition, protein homologs, secondary structure, and
protein alignment information. Both showed high levels of
accuracy when cross-validated against reference protein and
ncRNA datasets, and are likely to represent the vanguard of
future discrimination methods.
Bifunctional RNAs and the False Dichotomy
Despite recent advances such as support vector machines to
distinguish ncRNAs from mRNAs, large numbers of novel
transcripts remain ambiguous and difficult to definitively catego-
rize. CONC, for instance, estimated that ,28,000 FANTOM
cDNAs were ncRNAs, but .50% of these predictions fell outside
the reliable range [48]. Are these ncRNAs or mRNAs? Currently,
we cannot really say, but perhaps the question is itself flawed. After
all, reports are now emerging of transcripts that can not only be
translated into protein but also function independently as RNA,
and the very existence of such bifunctional RNAs challenges the
assumption that the RNA world can be neatly parsed between
mutually exclusive protein-coding and noncoding categories.
The first report of a bifunctional RNA was the human Steroid
Receptor Activator (SRA). Originally, SRA was characterized as an
ncRNA, which functioned at the transcript level to co-activate
steroid hormone receptors [43]. Remarkably, SRA transcripts have
now been shown to also encode a functional protein (SRAP) [50],
which appears to act antagonistically to SRA RNA at steroid
hormone receptors [51]. This raises the intriguing possibility that
bifunctional transcripts can negatively regulate their own func-
tions, although just how such a process operates and is controlled
requires further study.
Additional examples of bifunctional RNAs have also recently
emerged. The VegT RNA has been known for many years to encode
a proteinneeded to establishtheprimarygerm layersinXenopus [52].
However, VegT RNA has since been shown to also fulfill a separate
structural role in the cytokeratin network of primordial germ cells
[53]. In Drosophila, Oskar RNA was first characterized for its ability to
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development [54,55]. Recently, it has been found that Oskar mRNA
(specifically, its 39 UTR) functions independently of the Oskar
protein and is also essential for oogenesis [56]. Moreover, some
39UTRs can regulate cell proliferation and differentiation in
mammals,independentlyoftheirassociated protein-coding sequenc-
es, with perturbations of this information in certain cancers [57–62].
There are also examples in bacteria. SgrS is a 227 nt transcript from
Escherichia coli that functions to relieve the effects of glucose–
phosphate stress. It functions as an RNA by base-pairing with the
glucose transporter ptsG mRNA to negatively regulate its translation
and stability [63] but also encodes a 43 aa protein, which acts to
further reduce glucose uptake by inhibiting ptsG transporter activity
[64]. In this way, the SgrS RNA functions through two distinct
mechanisms to protect cells from glucose–phosphate stress. More-
over, these two functions appear to be physiologically redundant
[64], which indicates that in some situations bifunctionality
represents an inbuilt failsafe.
The number of documented cases of bifunctional RNAs is
limited. However, as mentioned earlier, conserved secondary
structures are commonly found in mRNAs, which suggests that
bifunctional RNAs might be widespread. Indeed, it was recently
predicted that in yeast as much as 5% of mRNAs function
independently as RNA, and it was estimated that this proportion is
likely to be significantly greater in higher eukaryotes [65]. To
further confound this dichotomy, recent studies show that mRNAs
that form duplex RNA structures within themselves, or with other
antisense RNAs or pseudogenes, may be processed into endoge-
nous siRNAs, therefore providing mRNAs with an additional fate
[66–68]. Even synonymous sites in codons, often thought to be
fully redundant, can encode additional subtle information. For
instance, ‘‘silent’’ mutations in synonymous sites can affect both
splicing and co-translational folding, and thereby alter protein
function [69,70]. This suggests that RNA carries much more cis-
and trans-acting information than previously imagined, both within
and beyond protein-coding sequences.
Conclusions
As the number of protein-coding genes continues to be revised
downward [25], there appears to be an ever-growing catalogue of
ncRNAs. Nevertheless, there is an ongoing lack of clarity
regarding the true number of ncRNAs within the genome. This
is at least partly due to the inherent difficulties in discriminating
ncRNAs from mRNAs and artifacts, especially amongst the
thousands of long transcripts that defy categorization by even the
most sophisticated of today’s classification methods. This situation
is further complicated by the emerging realization that the
transcriptome may not consist of discrete separable species, but
in reality comprise a series of overlapping clusters, of which many
span large genomic regions [5,71,72], potentially comprising an
information continuum. Looking ahead, we must also be prepared
to cast off our historical biases toward what appears now to be an
increasingly false dichotomy, and instead embrace the likelihood
that RNA is a molecular multi-tasker, whose roles can simulta-
neously bridge both protein-coding and noncoding domains, and
not only have more than one embedded function but also produce
multiple products.
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